HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Hirano Selected Research

OP 2507

5/2001The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Hirano Research Topics

Disease

18Neoplasms (Cancer)
08/2009 - 04/2000
7Chronic Kidney Failure (Chronic Renal Failure)
10/2010 - 05/2001
6Thrombosis (Thrombus)
06/2009 - 07/2000
6Embolism (Embolus)
12/2008 - 01/2001
6Inflammation (Inflammations)
02/2006 - 05/2000
6Aortic Dissection
12/2001 - 01/2000
4Death (Near-Death Experience)
11/2018 - 10/2001
4Insulin Resistance
12/2017 - 04/2000
4Infections
12/2015 - 12/2001
4Lung Neoplasms (Lung Cancer)
10/2007 - 05/2000
4Ischemic Stroke
09/2002 - 08/2000
4Coronary Artery Disease (Coronary Atherosclerosis)
09/2001 - 05/2000
3Necrosis
05/2014 - 08/2000
3Rheumatoid Arthritis
01/2013 - 09/2000
3Asthma (Bronchial Asthma)
05/2012 - 10/2000
3Atherosclerosis
10/2011 - 05/2001
3Type 2 Diabetes Mellitus (MODY)
10/2011 - 09/2001
3Chronic Obstructive Pulmonary Disease (COPD)
01/2008 - 09/2006
3Carcinoma (Carcinomatosis)
01/2004 - 04/2000
3Hypersensitivity (Allergy)
08/2003 - 10/2000
3Stroke (Strokes)
09/2002 - 01/2001
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2002 - 08/2001
3Fever (Fevers)
12/2001 - 01/2000
3Body Weight (Weight, Body)
03/2001 - 04/2000
2Hemorrhagic Shock
05/2014 - 05/2012
2Sarcoma (Soft Tissue Sarcoma)
06/2013 - 07/2000
2Aneurysm (Aneurysms)
03/2013 - 07/2001
2Diabetes Mellitus
06/2009 - 07/2001
2Intracranial Embolism
12/2008 - 01/2002
2Adenocarcinoma
02/2008 - 07/2000
2Adenocarcinoma of Lung
02/2008 - 10/2000
2Dyspnea (Shortness of Breath)
01/2007 - 03/2003
2Heart Failure
10/2006 - 07/2001
2Obesity
08/2006 - 10/2001
2Osteoporosis
05/2004 - 05/2001
2Disease Progression
01/2003 - 01/2001
2CADASIL
11/2002 - 12/2000
2Shock
01/2002 - 12/2001
2Cough
12/2001 - 03/2001
2Hepatocellular Carcinoma (Hepatoma)
10/2001 - 01/2001
2Hyperinsulinism (Hyperinsulinemia)
10/2001 - 04/2000
2Renal Insufficiency (Renal Failure)
10/2001 - 01/2000
2Otitis Media with Effusion
06/2001 - 04/2000
2Otitis Media
05/2001 - 11/2000
2Carcinogenesis
02/2001 - 05/2000

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
06/2013 - 03/2000
6DNA (Deoxyribonucleic Acid)IBA
06/2013 - 07/2000
6oxidized low density lipoproteinIBA
10/2011 - 12/2000
5Insulin (Novolin)FDA Link
12/2017 - 04/2000
4Adrenal Cortex Hormones (Corticosteroids)IBA
12/2017 - 02/2000
4Biological ProductsIBA
01/2013 - 05/2000
4LDL Lipoproteins (beta Lipoproteins)IBA
06/2007 - 05/2000
4Prednisolone (Predate)FDA LinkGeneric
10/2006 - 01/2000
4GelatinIBA
03/2003 - 01/2001
3dicarboxydine (DCD)IBA
11/2018 - 05/2014
3Fibrinolytic Agents (Antithrombotic Agents)IBA
12/2008 - 01/2001
3Pharmaceutical PreparationsIBA
05/2005 - 11/2000
3Anti-Allergic Agents (Antiallergic Agents)IBA
08/2003 - 10/2000
3EnzymesIBA
04/2003 - 07/2001
3Interleukin-6 (Interleukin 6)IBA
01/2003 - 05/2000
3CytokinesIBA
05/2002 - 05/2000
31-phenyl-3,3-dimethyltriazene (PDT)IBA
05/2001 - 07/2000
2Mycophenolic Acid (Cellcept)FDA LinkGeneric
12/2015 - 12/2007
2Immunosuppressive Agents (Immunosuppressants)IBA
12/2015 - 01/2000
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
05/2014 - 02/2006
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
05/2014 - 06/2009
2tocilizumab (atlizumab)FDA Link
01/2013 - 03/2009
2Glucose (Dextrose)FDA LinkGeneric
10/2011 - 04/2000
2ApolipoproteinsIBA
10/2010 - 02/2006
2HDL CholesterolIBA
10/2010 - 02/2006
2VimentinIBA
02/2008 - 12/2001
2Bronchodilator Agents (Bronchodilators)IBA
01/2008 - 01/2007
2Cyclosporine (Ciclosporin)FDA LinkGeneric
06/2007 - 11/2000
2CholesterolIBA
10/2006 - 12/2000
2C-Reactive ProteinIBA
08/2006 - 12/2001
2LeptinIBA
02/2006 - 04/2000
2Triglycerides (Triacylglycerol)IBA
03/2005 - 10/2001
2Diphosphonates (Bisphosphonates)IBA
05/2004 - 05/2001
2Interleukin-18 (Interleukin 18)IBA
08/2003 - 07/2003
2fluoromisonidazoleIBA
06/2002 - 08/2000
2GlucocorticoidsIBA
10/2001 - 07/2001
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2001 - 08/2000
2Dihematoporphyrin Ether (Porfimer Sodium)FDA Link
05/2001 - 07/2000
2Telomerase (Telomerase Reverse Transcriptase)IBA
01/2001 - 04/2000
2Monoclonal AntibodiesIBA
10/2000 - 08/2000

Therapy/Procedure

12Therapeutics
12/2017 - 09/2000
8Stents
06/2009 - 01/2000
8Lasers (Laser)
12/2008 - 01/2000
6Kidney Transplantation
12/2015 - 01/2000
5Catheters
03/2013 - 01/2001
5Photochemotherapy (Photodynamic Therapy)
01/2004 - 01/2000
4Transplantation
11/2018 - 08/2000
4Aftercare (After-Treatment)
12/2007 - 10/2000
3Injections
07/2003 - 01/2001
2Liver Transplantation
11/2018 - 05/2012
2Drug Therapy (Chemotherapy)
06/2007 - 02/2004
2Segmental Mastectomy (Lumpectomy)
11/2003 - 05/2002
2Solid-State Lasers
01/2002 - 12/2001
2Thoracotomy
12/2001 - 03/2001
2Optical Fibers
05/2001 - 01/2001